Self-medication among adults with chronic health conditions: a population-based cross-sectional survey in Saudi Arabia

BMJ Open. 2023 Apr 17;13(4):e069206. doi: 10.1136/bmjopen-2022-069206.

Abstract

Objectives: This study aimed to assess the prevalence of self-medication (SM), the reasons for SM and the relationship between chronic health conditions and SM among adult individuals.

Setting: This was an online questionnaire-based cross-sectional study disseminated on different social media platforms in Saudi Arabia.

Participants: Saudi Arabia sample of adult individuals aged 18 and above.

Primary and secondary outcome measures: Primary outcome was SM, measured using the following question: 'During the past 6 months, have you used any medicines or dietary supplements, or herbal medicines or vitamins not prescribed or recommended by a doctor?' A positive answer indicates a self-medicated participant.

Results: Out of 1645 individuals who viewed the study link, 1295 participants completed the survey with a response rate of 95.1%. Overall, 989 (76.4%) participants reported practicing SM in the past 6 months. SM was higher among younger participants, women, those with higher education levels and high income, and working in the health field. About 198 (73.3%) who have chronic conditions practised SM for chronic health conditions, such as (hypertension and hypercholesterolemia). Previous experience with the same illness (n=530, 25.7%) and attempting to save time (n=466, 22.6%) were the main reasons behind SM, according to the participants. Adverse drug events were reported by 204 (20.6%) of self-medicating individuals and 274 (64.9%) of them reported discontinuing SM.

Conclusions: The findings of this study indicate a high prevalence rate of SM among the adult population in Saudi Arabia. Individuals with chronic health conditions reported a high rate of SM. Launching public education campaigns to improve public awareness of the harms of SM if misused, especially among those with chronic health conditions, is essential.

Keywords: adverse events; clinical pharmacology; epidemiology; health & safety.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Chronic Disease
  • Cross-Sectional Studies
  • Dietary Supplements*
  • Female
  • Humans
  • Hypertension*
  • Saudi Arabia / epidemiology
  • Surveys and Questionnaires